Literature DB >> 22172972

Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories.

Barbara S Drolet1, Hana M Weingartl, Jieyuan Jiang, James Neufeld, Peter Marszal, Robbin Lindsay, Myrna M Miller, Markus Czub, William C Wilson.   

Abstract

Rift Valley fever virus (RVFV) is a zoonotic insect transmitted virus endemic to Africa and the Arabian Peninsula. Infection causes abortions and high mortality in newborn ruminants. The overall human infection rate is <1%; however, fatality rates in those with severe clinical disease have been reported as high as 29%. The potential of RVFV as a bioterrorism agent and/or being accidentally introduced into North America is widely recognized. Currently, regional veterinary biosafety level 2 (BSL-2) diagnostic laboratories lack safe, modern, validated diagnostic tests to detect RVFV. An existing one-step real-time RT-PCR (rRT-PCR) assay was modified for quick virus inactivation for use in BSL-2 laboratories, evaluated on serum and tissue samples from experimentally infected lambs and calves, and compared to virus isolation. Viremia was detected in all inoculated sheep with titers reaching 10(6.5) plaque forming units/ml, or up to 10(10) viral RNA copies/ml. Viremia in calves was lower and not detected in all inoculated animals; however, all animals became transiently febrile and were infected as determined by rRT-PCR of tissues. Virus was isolated from rRT-PCR-positive liver and/or spleen in 33% of lamb and 41% of calf samples between 2 and 7 days post inoculation. For RVFV antigen detection, reagents are typically produced at BSL-3Ag or BSL-4 conditions and require inactivation and safety testing for use outside of containment. In this study, antiserum against recombinant RVFV-nucleocapsid (N) was produced to develop an immunohistochemical (IHC) assay which was subsequently evaluated on formalin fixed lamb and calf tissues at BSL-2 laboratory conditions. Antigen was detected by IHC in 79% of rRT-PCR-positive sheep and 70% of rRT-PCR-positive calf tissues tested. Once validated and approved by national regulatory agencies, these assays can be safely produced and distributed to regional diagnostic laboratories, providing capacity for early detection of RVFV in suspected ruminant samples.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22172972     DOI: 10.1016/j.jviromet.2011.11.025

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

2.  Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.

Authors:  Myrna M Miller; Kristine E Bennett; Barbara S Drolet; Robbin Lindsay; James O Mecham; Will K Reeves; Hana M Weingartl; William C Wilson
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

3.  Reagents for detection of Rift Valley fever virus infection in sheep.

Authors:  Brian J Shiell; Siying Ye; Jennifer A Harper; Brenda van der Heide; Gary Beddome; Adam J Foord; Wojtek P Michalski; John Bingham; Grantley R Peck
Journal:  J Vet Diagn Invest       Date:  2020-05-25       Impact factor: 1.279

4.  Innate immune response to Rift Valley fever virus in goats.

Authors:  Charles K Nfon; Peter Marszal; Shunzhen Zhang; Hana M Weingartl
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

5.  Experimental Infection of Domestic Piglets (Sus scrofa) with Rift Valley Fever Virus.

Authors:  Lorelei L Clarke; Daniel G Mead; Mark G Ruder; Deborah L Carter; Jennifer Bloodgood; Elizabeth Howerth
Journal:  Am J Trop Med Hyg       Date:  2021-10-25       Impact factor: 3.707

6.  Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.

Authors:  Hana M Weingartl; Shunzhen Zhang; Peter Marszal; Alan McGreevy; Lynn Burton; William C Wilson
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

7.  Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.

Authors:  Sandiswa Mbewana; Ann E Meyers; Brandon Weber; Vuyokazi Mareledwane; Maryke L Ferreira; Phelix A O Majiwa; Edward P Rybicki
Journal:  BMC Biotechnol       Date:  2018-12-11       Impact factor: 2.563

8.  Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus.

Authors:  William C Wilson; A Sally Davis; Natasha N Gaudreault; Bonto Faburay; Jessie D Trujillo; Vinay Shivanna; Sun Young Sunwoo; Aaron Balogh; Abaineh Endalew; Wenjun Ma; Barbara S Drolet; Mark G Ruder; Igor Morozov; D Scott McVey; Juergen A Richt
Journal:  Viruses       Date:  2016-05-23       Impact factor: 5.048

9.  A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.

Authors:  Bonto Faburay; William C Wilson; Natasha N Gaudreault; A Sally Davis; Vinay Shivanna; Bhupinder Bawa; Sun Young Sunwoo; Wenjun Ma; Barbara S Drolet; Igor Morozov; D Scott McVey; Juergen A Richt
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

Review 10.  Rift valley fever: diagnostic challenges and investment needs for vaccine development.

Authors:  Velislava Petrova; Paul Kristiansen; Gunnstein Norheim; Solomon A Yimer
Journal:  BMJ Glob Health       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.